PAUL N CLARK

CIK 1222248 · Chairman, CEO & President · last filed 2021-04-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$38.68M

Companies

7

Total Filings

69

Lifetime Open-Market Net

-$386.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AGEN Director $3.29 $0 3 2021-04-05
KEYS Director 73,620 $357.51 $26.32M $0 10 2021-03-23
A Director 95,234 $129.79 $12.36M -$2.46M 28 2021-03-22
BIOLASE, INC (BIOL) Delisted Director 1,407,807 $0.02 $24.5K $2.07M 13 2017-07-03
AMYLIN PHARMACEUTICALS INC (AMLN) Delisted Director 4,908 $0 11 2012-04-13
Talecris Biotherapeutics Holdings Corp. (TLCR) Delisted Director 12,715 $0 1 2010-04-05
ICOS CORP (ICOS) Delisted Chairman, CEO & President 0 $0 2 2007-01-30

Recent Filings · Page 3 of 7

69 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-11-18 A Sell (S) −4,704 -$213.1K EDGAR
2016-10-04 BIOLASE, INC (BIOL) Delisted Conv (C) +221,200 $250.0K EDGAR
2016-08-03 BIOLASE, INC (BIOL) Delisted Buy (P) $0 EDGAR
2016-05-10 BIOLASE, INC (BIOL) Delisted Grant (A) $0 EDGAR
2016-03-21 KEYS Grant (A) +16,743 $435.0K EDGAR
2016-03-18 A Grant (A) +4,704 $184.8K EDGAR
2015-11-12 BIOLASE, INC (BIOL) Delisted Buy (P) +134,579 $101.4K EDGAR
2015-11-09 KEYS Grant (A) +9,278 $352.1K EDGAR
2015-08-31 BIOLASE, INC (BIOL) Delisted Exer (M) +9,217 $0 EDGAR
2015-04-29 BIOLASE, INC (BIOL) Delisted Grant (A) $0 EDGAR
Showing 2130 of 69
Page 3 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.